Celularity Inc Return Tang Equity
Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
- Celularity Inc return tang equity for the quarter ending 2025-12-31 was 174.81%, a 78.69% decline year-over-year.
- Celularity Inc return tang equity for the quarter ending 2025-09-30 was 231.26%, a change of 3705.19% year-over-year.
- Celularity Inc return tang equity for the quarter ending 2025-06-30 was 181.22%, a change of 1191.79% year-over-year.
- Celularity Inc return tang equity for the quarter ending 2025-03-31 was 264.50%, a change of 1355.44% year-over-year.
- Celularity Inc return tang equity for fiscal 2025 was 174.81%, a 78.69% decline from fiscal 2024.
- Celularity Inc return tang equity for fiscal 2024 was 820.23%, a change of 1662.27% from fiscal 2023.
- Celularity Inc return tang equity for fiscal 2023 was -842.03%, a 4058.19% decline from fiscal 2022.
- Celularity Inc return tang equity for fiscal 2022 was 21.27%, a 91.80% decline from fiscal 2021.
- Available history
- 2019-12-31 to 2025-12-31
- Data captured
Historical Return Tang Equity
Annual Return Tang Equity
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |